2Firsts to Host Special Session at InterTabac on September 19

Sep.15.2025
2Firsts to Host Special Session at InterTabac on September 19
2Firsts will host a special session at the InterTabac exhibition in Dortmund on September 19, 2025, under the theme “From Change to Opportunity.” As an official media partner, 2Firsts will highlight technology, supply chain, market, and capital opportunities while fostering global dialogue.

[September 15, 2025] Global NGP media and research platform 2Firsts announced that it will host a special forum at the InterTabac exhibition in Dortmund, Germany, on the afternoon of September 19, 2025. The event, titled 2Firsts Connect @ InterTabac: From Change to Opportunity, has received strong support from the organizers and will be an integral part of the InterTabac Conference.

 

The global NGP industry and tobacco harm reduction are undergoing profound transformation. The sector urgently needs to address the “big questions” and “new trends,” inspiring fresh thinking and concrete action to support more sustainable global development and to remain true to the mission of harm reduction.

 

Against this backdrop, 2Firsts Connect @ InterTabac will focus on industry trends and opportunities, covering topics such as global e-cigarette product innovations, China’s supply chain and regulatory dynamics, the U.S. market transition, global THR strategies, and capital market perspectives. Drawing on 2Firsts’ extensive global reporting and research, the session will deliver both exclusive and forward-looking insights.

 

2Firsts to Host Special Session at InterTabac on September 19
2Firsts Connect@ InterTabac: From Change to Opportunity|Source:2Firsts

 

The session will be hosted by Alan Zhao, Co-founder & CEO of 2Firsts, together with the 2Firsts research and editorial team, including Global Editor in Chief Taco Tuinstra, who will join either on-site or via remote link. Additional distinguished guest speakers will also participate, including William Wu, Deputy Head of the Research Institute at Tianfeng Securities, with more speakers to be announced soon.

 

As an international media and research platform dedicated to the NGP industry and tobacco harm reduction, 2Firsts has successfully organized multiple seminars and industry events in Shenzhen, China, earlier this year. Its debut at InterTabac marks a new milestone for 2Firsts Events as it steps onto the global stage, further fostering international dialogue across industry, policy, science, capital, and media.

 

We warmly invite industry peers, partners, and media to join us in exploring the future of the NGP industry.

 

Event Time: September 19, 2025 | 3:00 PM – 5:30 PM

Event Venue: InterTabac Exhibition, Nowgorod Room (North Entrance), Dortmund, Germany

Contact: alan@2firsts.com

New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City's Department of Consumer and Worker Protection (DCWP) opened applications on November 2, 2026, for a lottery covering tobacco and electronic cigarette retail dealer licenses, with a deadline of 5 p.m. New York local time on November 30. According to the city's October 1 notice, 55 electronic cigarette retail license slots are available across 23 community districts, including 28 in Brooklyn, alongside 322 tobacco retail license slots across 41 districts. Businesses must enter the lottery and, if invited, complete licensing requirements within 65 days. New York City continues to restrict e-cigarette retail sales to tobacco-flavored or unflavored products, while city retail licenses do not replace FDA product marketing authorization.
Market
Nov.04
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Several U.S. states have incorporated the September 9, 2020 PMTA filing deadline into eligibility rules for certain vaping products. CrossBar 20K drew attention after appearing on Pennsylvania's 163-entry directory. A broader 2Firsts investigation found that related registration businesses also listed KUMI and CROSSBAR SIX products, with 171 KUMI-related entries across Louisiana, Nebraska and Wisconsin. Corporate records link Scott Silverman to Blue Nine LLC and VR Products I LLC. PMTA compliance expert Mr. K said historical applications and nicotine-analogue products may offer two different approaches to state-directory access.
Regulations
Oct.26
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
Brad Rodu Says Declining Cigarette Smoking Is Key to Tobacco Harm Reduction | 2Firsts Interview
Brad Rodu Says Declining Cigarette Smoking Is Key to Tobacco Harm Reduction | 2Firsts Interview
After more than 30 years researching tobacco harm reduction, University of Louisville professor Brad Rodu says opposition to smoke-free alternatives still surprises him. In an exclusive 2Firsts interview in Manila, he argued that declining smoking rates represent progress even if nicotine use rises, discussed nicotine and cancer, and examined Sweden's snus experience and youth vaping. Rodu welcomed recent FDA decisions but criticized slow reviews and poor risk communication. He called a change in the WHO's stance potentially significant, while doubting it would happen soon.
Nov.20